Monday, December 31, 2018

Lupin gets USFDA nod for Clobazam Oral Suspension

Lupin gets USFDA nod for Clobazam Oral Suspension The drug is indicated for treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients of two years of age or older.

from Moneycontrol Business News http://bit.ly/2SzDNZX

No comments:

Post a Comment

Vikas Khemani on key triggers that will shape the market’s next big move

Most people kind of turned bearish on global concerns, oil prices. So, people tend to kind of extrapolate more bad news. So that has happene...